Homestead Advisers Corp Zoetis Inc. Transaction History

Homestead Advisers Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	BUY	$145.48 - $175.02 $21,822 - $26,253	150 Added 14.62%	1,176 $195,000
Q4 2022 Feb 03, 2023	BUY	$131.14 - $157.47 $4,852 - $5,826	37 Added 3.74%	1,026 $150,000
Q3 2022 Nov 07, 2022	BUY	$148.29 - $182.55 $3,855 - $4,746	26 Added 2.7%	989 $147,000
Q2 2022 Aug 01, 2022	BUY	$155.97 - $200.09 $30,102 - $38,617	193 Added 25.06%	963 $166,000
Q1 2022 May 12, 2022	BUY	$181.39 - $234.03 $19,408 - $25,041	107 Added 16.14%	770 $145,000
Q4 2021 Feb 07, 2022	BUY	$193.69 - $247.03 $30,409 - $38,783	157 Added 31.03%	663 $162,000
Q3 2021 Nov 05, 2021	BUY	$189.29 - $209.69 $32,936 - $36,486	174 Added 52.41%	506 $98,000
Q2 2021 Aug 02, 2021	BUY	$155.9 - $187.99 $51,758 - $62,412	332 New	332 $62,000

1,957

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Homestead Advisers Corp, based on Form 13F filings with the SEC.

Stay updated on Homestead Advisers Corp with notifications on news.